From HTS to Market: the Discovery and Development of Maraviroc, a CCR5 Antagonist for the Treatment of HIV - Accounts in Drug Discovery Case Studies in Medicinal Chemistry - page 212

68. P. K. Dorr, K. Todd, R. Irvine, N. Robas, A. Thomas, M. Fidock, H.
Sultan, J. Mills, F. Perrucio, K. Burt, G. Rickett, H. Perkins, P. Grin,
M. Macartney, D. Hamilton, M. Westby and M. Perros, presented at the
45th Interscience Conference on Antimicrobial Agents and Chemother-
apy, Washington, 2005.
69. M. Westby, C. Smith-Burchnell, J. Mori, M. Lewis, J. Whitcomb,
C. Petropoulos and M. Perros, presented at the XIII International HIV
Drug Resistance Workshop, Tenerife, 2004.
70. M. Westby, C. Smith-Burchnell, J. Mori, M. Lewis, M. Mosley,
M. Stockdale, P. Dorr, G. Ciaramella and M. Perros, J. Virol., 2007, 81,
2359-2371.
71. M. Westby, M. Lewis, J. Whitcomb, M. Youle, A. L. Pozniak, I. T.
James, T. M. Jenkins, M. Perros and E. van der Ryst, J. Virol., 2006, 80,
4909-4920.
72. M. Westby, C. Smith-Burchnell, D. Hamilton, N. Robas, B. Irvine,
M. Fidock, J. Mills, F. Perruccio, J. Mori, M. Macartney, C. Barber,
P. Dorr and M. Perros, presented at the 12th Conference on Retroviruses
and Opportunistic Infections, Boston, 2005.
73. J. A. Kramer, Expert Opin. Drug Discovery, 2008, 3, 707-713.
74. Pfizer Ltd., Pat. Appl., WO 2005/033107, 2005.
75. P. Dorr, M. Westby, L. McFadyen, J. Mori, J. Davis, F. Perruccio,
R. Jones, P. Stupple, D. Middleton and M. Perros, presented at the
15th Conference on Retroviruses and Opportunistic Infections, Boston,
2008.
76. A. Hall, Future Med. Chem., 2009, 1, 431-434.
77. P. Dorr, M. Westby, L. McFadyen, J. Mori, J. Davis, F. Perruccio,
R. Jones, P. Stupple, D. Middleton and M. Perros, presented at the
15th Conference on Retroviruses and Opportunistic Infections, Boston,
2007.
78. C. G. Barber, D. C. Blakemore, J.-Y. Chiva, R. L. Eastwood, D. S.
Middleton and K. A. Paradowski, Bioorg. Med. Chem. Lett., 2009, 19,
1075-1079.
79. C. G. Barber, D. C. Blakemore, J.-Y. Chiva, R. L. Eastwood, D. S.
Middleton and K. A. Paradowski, Bioorg. Med. Chem. Lett., 2009, 19,
1499-1503.
80. A. Wood, D. Armour, F. D. King and G. Lawton, Prog. Med. Chem.,
2005, 43, 239-271.
81. R. J. Riley, A. J. Parker, S. Trigg and C. N. Manners, Pharm. Res., 2001,
18, 652-655.
82. M. Cereijido, J. Ehrenfeld, I. Meza and A. Martı´ nez-Palomo, J. Membr.
Biol., 1980, 52, 147-159.
83. K. Maeda, K. Yoshimura, S. Shibayama, H. Habashita, H. Tada, K.
Sagawa, T. Miyakawa, M. Aoki, D. Fukushima and H. Mitsuya, J. Biol.
Chem., 2001, 276, 35194-35200.
84. M. Baba, Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 5698.